20-year psittacosis peak; Regional flu update

The ECDC’s Week 13 Communicable Disease Threats Report (CDTR) comments on a recent increase in human psittacosis infections reported over this last winter period in Sweden - the 60 cases notified between November and March amount to a 20-year high as yearly averages had ranged between 20 and 25 from 2013-17. The CDTR notes that ‘the majority of cases were infected through contact with wild birds and bird tables’ and ‘healthcare providers should be aware of the increased risk of infection in people keeping or handling birds and their environments’.

INFLUENZA data for the EU region on Flu News Europe website reveals low activity in most countries (‘influenza type A virus detections dominated with more A(H3N2) than A(H1N1)pdm09 viruses’), with the exception of Finland, Romania, Kosovo and Bosnia and Herzegovina which report medium levels. Additionally, ‘circulating viruses in the European Region remain susceptible to neuraminidase inhibitors supporting use of antiviral treatment according to national guidelines’.

Advice for travellers

Seasonal flu is the most common vaccine-preventable travel-related illness because it is a potential risk during every stage of the journey. Whether you are travelling within Australia or overseas, Travelvax recommends vaccination, when available, for all travellers over 6 months of age. Read more about influenza.

Before you travel, call Travelvax Australia’s telephone advisory service on 1300 360 164 (toll-free from landlines) for country-specific advice and information. You can also make an appointment at your nearest Travelvax clinic to obtain vaccinations, medication to prevent or treat illness, and accessories for your journey.